Time to reduce implementation gaps of lipid-lowering therapy
Video navigation menu
- ESC/EAS risk-based LDL-c goals 00:56
- The basis of the lower LDL-c recommendation for clinical practice 01:58
- Use of lipid-lowering treatments and their impact on health and disease outcomes 02:32
- Implementation gaps and how combination therapy can overcome this 04:04
- Summary 08:58
This presentation by Prof. Kausik Ray, MD was part of the EBAC-accredited symposium "PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities" held during the virtual ESC Congress 2020.
Prof. Kausik Ray, MD, is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Sanofi and Amgen